Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.
|
J Biol Chem
|
2002
|
9.76
|
2
|
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.
|
J Biol Chem
|
2001
|
5.12
|
3
|
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
|
J Biol Chem
|
2002
|
4.84
|
4
|
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
|
J Clin Invest
|
2005
|
4.81
|
5
|
Brain IRS2 signaling coordinates life span and nutrient homeostasis.
|
Science
|
2007
|
4.80
|
6
|
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.
|
J Clin Invest
|
2002
|
4.05
|
7
|
Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.
|
Mol Cell Biol
|
2005
|
3.50
|
8
|
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.
|
Cell Metab
|
2008
|
3.22
|
9
|
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.
|
J Biol Chem
|
2002
|
2.45
|
10
|
Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction.
|
Nat Med
|
2011
|
2.40
|
11
|
Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.
|
J Clin Invest
|
2004
|
2.34
|
12
|
RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function.
|
J Biol Chem
|
2005
|
2.32
|
13
|
Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.
|
Nat Med
|
2005
|
2.18
|
14
|
Insulin-like signaling, nutrient homeostasis, and life span.
|
Annu Rev Physiol
|
2008
|
2.07
|
15
|
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation.
|
J Neurosci
|
2003
|
2.03
|
16
|
Pdx1 restores beta cell function in Irs2 knockout mice.
|
J Clin Invest
|
2002
|
1.95
|
17
|
Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor.
|
J Clin Invest
|
2002
|
1.93
|
18
|
Foxo1 integrates insulin signaling with mitochondrial function in the liver.
|
Nat Med
|
2009
|
1.85
|
19
|
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.
|
J Clin Invest
|
2003
|
1.83
|
20
|
Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.
|
J Clin Invest
|
2005
|
1.80
|
21
|
Insulin signaling meets mitochondria in metabolism.
|
Trends Endocrinol Metab
|
2010
|
1.77
|
22
|
The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.
|
Mol Cell Biol
|
2009
|
1.69
|
23
|
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2.
|
Nat Struct Mol Biol
|
2008
|
1.67
|
24
|
Irs1 serine 307 promotes insulin sensitivity in mice.
|
Cell Metab
|
2010
|
1.67
|
25
|
Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.
|
Mol Cell Biol
|
2004
|
1.65
|
26
|
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation.
|
Biochem Biophys Res Commun
|
2004
|
1.59
|
27
|
Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.
|
Antioxid Redox Signal
|
2010
|
1.59
|
28
|
Involvement of insulin receptor substrate 2 in mammary tumor metastasis.
|
Mol Cell Biol
|
2004
|
1.55
|
29
|
Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function.
|
J Biol Chem
|
2005
|
1.51
|
30
|
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.
|
Diabetes
|
2003
|
1.51
|
31
|
Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling.
|
J Biol Chem
|
2003
|
1.47
|
32
|
Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
|
PLoS Biol
|
2008
|
1.40
|
33
|
Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL.
|
J Biol Chem
|
2002
|
1.34
|
34
|
Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.
|
Diabetes
|
2012
|
1.32
|
35
|
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.
|
Cancer Res
|
2002
|
1.32
|
36
|
Targeted disruption of ROCK1 causes insulin resistance in vivo.
|
J Biol Chem
|
2009
|
1.31
|
37
|
Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.
|
Mol Cell Biol
|
2002
|
1.21
|
38
|
Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
|
Mol Cell Biol
|
2006
|
1.19
|
39
|
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice.
|
Diabetes
|
2004
|
1.18
|
40
|
Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity.
|
Am J Physiol Cell Physiol
|
2004
|
1.16
|
41
|
The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis.
|
Diabetes
|
2007
|
1.15
|
42
|
Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.
|
Diabetes
|
2013
|
1.14
|
43
|
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease.
|
J Clin Invest
|
2011
|
1.14
|
44
|
Chronic activation of a designer G(q)-coupled receptor improves β cell function.
|
J Clin Invest
|
2013
|
1.13
|
45
|
Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review.
|
Environ Health Perspect
|
2012
|
1.13
|
46
|
Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways.
|
Mol Cell Biol
|
2010
|
1.13
|
47
|
Direct autocrine action of insulin on β-cells: does it make physiological sense?
|
Diabetes
|
2013
|
1.12
|
48
|
Insulin receptor substrate proteins and diabetes.
|
Arch Pharm Res
|
2004
|
1.12
|
49
|
The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
|
Mol Endocrinol
|
2006
|
1.08
|
50
|
Signaling pathways: the benefits of good communication.
|
Curr Biol
|
2004
|
1.04
|
51
|
Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis.
|
J Biol Chem
|
2005
|
1.00
|
52
|
Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells.
|
J Neurosci
|
2005
|
1.00
|
53
|
Phosphorylation of Irs1 at SER-522 inhibits insulin signaling.
|
Mol Endocrinol
|
2007
|
0.98
|
54
|
IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
|
Hepatology
|
2004
|
0.98
|
55
|
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart.
|
J Clin Invest
|
2013
|
0.97
|
56
|
IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action.
|
Cell Metab
|
2012
|
0.95
|
57
|
The AKTion in non-canonical insulin signaling.
|
Nat Med
|
2012
|
0.94
|
58
|
Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).
|
J Biol Chem
|
2011
|
0.93
|
59
|
Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
|
Am J Physiol Endocrinol Metab
|
2010
|
0.93
|
60
|
Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.
|
Mol Cell Biol
|
2013
|
0.92
|
61
|
Insulin signaling after exercise in insulin receptor substrate-2-deficient mice.
|
Diabetes
|
2002
|
0.92
|
62
|
Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.
|
J Biol Chem
|
2014
|
0.92
|
63
|
Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice.
|
Endocrinology
|
2009
|
0.90
|
64
|
Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells.
|
J Biol Chem
|
2013
|
0.88
|
65
|
Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes.
|
Diabetes
|
2012
|
0.88
|
66
|
Foxo1 in hepatic lipid metabolism.
|
Cell Cycle
|
2010
|
0.87
|
67
|
Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
|
Am J Physiol Endocrinol Metab
|
2005
|
0.87
|
68
|
Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes.
|
PLoS One
|
2013
|
0.87
|
69
|
IRS-2 Deficiency impairs NMDA receptor-dependent long-term potentiation.
|
Cereb Cortex
|
2011
|
0.87
|
70
|
Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transport.
|
J Biol Chem
|
2005
|
0.85
|
71
|
Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling.
|
Sci Signal
|
2013
|
0.85
|
72
|
Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice.
|
Front Biosci
|
2007
|
0.84
|
73
|
Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3beta?
|
BMC Dev Biol
|
2010
|
0.84
|
74
|
The IRS2 Gly1057Asp variant is associated with human longevity.
|
J Gerontol A Biol Sci Med Sci
|
2009
|
0.83
|
75
|
Irs2 inactivation suppresses tumor progression in Pten+/- mice.
|
Am J Pathol
|
2008
|
0.83
|
76
|
Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
|
J Histochem Cytochem
|
2005
|
0.82
|
77
|
Insulin receptor substrate 1 (IRS-1) plays a unique role in normal epidermal physiology.
|
J Cell Physiol
|
2007
|
0.82
|
78
|
Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis.
|
Endocrinology
|
2009
|
0.82
|
79
|
Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.
|
Am J Physiol Endocrinol Metab
|
2007
|
0.80
|
80
|
Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway.
|
J Biol Chem
|
2002
|
0.80
|
81
|
Diabetes forum: Extreme makeover of pancreatic alpha-cells.
|
Nature
|
2010
|
0.79
|
82
|
Integrating metabolism and longevity through insulin and IGF1 signaling.
|
Endocrinol Metab Clin North Am
|
2012
|
0.78
|
83
|
Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.
|
FEBS J
|
2013
|
0.77
|
84
|
Breathing room: the (un)natural history of adipose microhypoxia and insulin resistance.
|
Diabetes
|
2009
|
0.75
|
85
|
kNOXing on the door of selective insulin resistance.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.75
|
86
|
Essential role of protein kinase C zeta in the impairment of insulin-induced glucose transport in IRS-2-deficient brown adipocytes.
|
FEBS Lett
|
2003
|
0.75
|